ESR1 and breast cancer: Molecules identified as critical in carcinogenesis and cancer progression may help classify patients at the same stage into different subgroups in terms of their prognosis, e.g., estrogen receptor (ER) status and human epidermal growth factor receptor-2 (HER2) status in breast cancer patients [6].